News from Sanofi

( EuronextParis:SAN,NYSE:SNY)

Jul 08, 2014, 08:01 ET

FDA Accepts Sanofi's New Drug Application for Basal Insulin Toujeo®

 Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the...

Jun 30, 2014, 10:00 ET

Kids at risk of severe allergies attend soccer clinic hosted by the Montreal Impact and Allerject™

MONTREAL, June 30, 2014 /CNW Telbec/ - For more than 75 youngsters with life-threatening allergies, participating in a soccer clinic hosted by...

Jun 14, 2014, 13:02 ET

Sanofi Reports Positive Phase 3 Results for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL)

Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that, in a pooled analysis, investigational therapy Toujeo® (insulin glargine [rDNA...

Jun 14, 2014, 13:02 ET

Patients Continuing On Sanofi's Lantus® Had Lower Blood Sugar Levels Than Those who Switched to Insulin Detemir

Sanofi US announced today results from a real world outcome study of type 2 diabetes (T2D) patients that show switching from Lantus® (insulin...

Jun 14, 2014, 13:02 ET

Sanofi's Lyxumia® (lixisenatide) Showed More Pronounced After-Test-Meal Blood Sugar Lowering than Liraglutide when Both were Added to Insulin Glargine

 Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that Lyxumia® (lixisenatide) met the primary endpoint in an 8-week head-to-head...

Jun 14, 2014, 13:01 ET
Cities for Life helps improve diabetes management. (PRNewsFoto/Sanofi US)

Cities for Life Increased Community Support and Showed Improved Clinical Measures for People Living With or At Risk for Type 2 Diabetes

The American Academy of Family Physicians Foundation announced today that the Cities for Life program, supported by Sanofi US, helped decrease...

May 19, 2014, 12:37 ET

Sanofi Pasteur annonce des résultats encourageants pour l'essai de Phase II du candidat vaccin Clostridium difficile au congrès de l'ECCMID

- L'étude montre que le vaccin induit une réponse immunitaire contre les principales toxines et permet d'identifier le dosage pour les...

May 19, 2014, 08:00 ET

Sanofi Pasteur Announces Favorable Phase II Study Results for Investigational Clostridium difficile Vaccine at the American Society for Microbiology Meeting

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), presented Phase II trial (H-030-012) results for an investigational...

May 13, 2014, 08:00 ET

Jerome Bettis, Sanofi US and Allergy Foundation Launch Severe, Life-Threatening Allergies Quiz

Professional football icon Jerome Bettis, the Asthma and Allergy Foundation of America (AAFA) and Sanofi US, the makers of Auvi-Q®...

May 12, 2014, 10:28 ET
Veterans Advancing ALS/MND Team Wins Sanofi's Partners in Patient Health and North America Research & Development Hub Collaborate Innovate Challenge (PRNewsFoto/Sanofi)

Veterans Advancing ALS/MND Wins Sanofi US Innovation Challenge: Collaborate Innovate

 Sanofi US announced the winner of its second Innovation Challenge: Collaborate Innovate. The winner, Veterans Advancing ALS/MND, is a...

May 12, 2014, 08:19 ET

National Survey Reveals Mothers Are Unaware of the CDC Recommendations for Prevention of Meningococcal Meningitis, a Disease That Can Potentially Kill in 24 Hours

Although meningococcal meningitis is a rare but serious disease that can potentially take a life in 24 hours,1 a national survey revealed that more...

Apr 29, 2014, 08:10 ET
Sanofi logo.  (PRNewsFoto/Sanofi)

Sanofi Q1 2014 Business EPS up 5.8% at CER

Sanofi (NYSE: SNY; EURONEXT: SAN) Q1 2014 Change (reported) Change (CER) Net sales €7,842m -2.7% +3.5% Business...

Apr 29, 2014, 02:05 ET

Sanofi Q1 2014 Results - Interview with CFO Jérôme Contamine

Sanofi, a global and diversified healthcare leader, reports results for the first-quarter of 2014. Jérôme Contamine, Chief Financial...

Apr 29, 2014, 02:02 ET

Sanofi - Résultats T1 2014 - Interview du Directeur Financier Jérôme Contamine

Sanofi, un leader mondial et diversifié de la santé, publie ses résultats pour le premier trimestre 2014. Le Vice-Président...

Apr 15, 2014, 09:00 ET
Nasacort Allergy 24HR Nasal Spray (PRNewsFoto/Sanofi US)

Basketball Hall of Famer Nancy Lieberman Teams Up with New Nasacort® Allergy 24HR to Help Allergy Sufferers Put the Full 'Cort Press on Nasal Allergy Symptoms

 Nancy Lieberman, basketball hall of famer, coach and mom, has teamed up with Sanofi's consumer healthcare division Chattem Inc. to introduce a...

Apr 07, 2014, 12:09 ET

Gardasil® als 2-Dosen-Schema für Kinder im Alter von 9 bis 13 Jahren in der Europäischen Union zugelassen

 Ein neues 2-Dosen-Schema des HPV-Vierfachimpfstoffs Gardasil® ist ab sofort für Jugendliche...

Apr 07, 2014, 08:46 ET

Gardasil® recibe la aprobación en la UE para un programa de 2 dosis en niños de 9 a 13 años

 Un nuevo régimen de 2 dosis para Gardasil®, la vacuna cuadrivalente HPV, ya disponible para adolescentes Sanofi...

Apr 07, 2014, 03:00 ET

Le vaccin Gardasil® a été approuvé par l'Union européenne dans le cadre d'un schéma de vaccination en 2 doses chez les enfants entre 9 et 13 ans

 Le vaccin anti-HPV quadrivalent est désormais disponible dans le cadre d'un nouveau schéma de vaccination en 2 doses pour les...

Apr 01, 2014, 09:13 ET

Sanofi Pasteur Announces FDA Has Expanded Age Indication of Adacel® Tdap Vaccine to Include Persons 10 Years of Age

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has...

Mar 03, 2014, 01:00 ET

Inactivated Polio Vaccines Broadly Available for the World's Children in the Drive Toward Polio Eradication

- Sanofi Pasteur works with global partners to make available unparalleled quantities of affordable Inactivated Polio Vaccine (IPV) - Sanofi...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer